165 related articles for article (PubMed ID: 29070791)
1. Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer's disease.
Li H; Hong G; Lin M; Shi Y; Wang L; Jiang F; Zhang F; Wang Y; Guo Z
Sci Rep; 2017 Oct; 7(1):14027. PubMed ID: 29070791
[TBL] [Abstract][Full Text] [Related]
2. A simple way to detect disease-associated cellular molecular alterations from mixed-cell blood samples.
Hong G; Li H; Li M; Zheng W; Li J; Chi M; Cheng J; Guo Z
Brief Bioinform; 2018 Jul; 19(4):613-621. PubMed ID: 28200092
[TBL] [Abstract][Full Text] [Related]
3. Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood.
Li H; Guo Z; Guo Y; Li M; Yan H; Cheng J; Wang C; Hong G
Oncotarget; 2016 Apr; 7(15):19089-98. PubMed ID: 26943045
[TBL] [Abstract][Full Text] [Related]
4. Identification of dysregulated genes and pathways of different brain regions in Alzheimer's disease.
Wang Y; Wang Z
Int J Neurosci; 2020 Nov; 130(11):1082-1094. PubMed ID: 32019384
[No Abstract] [Full Text] [Related]
5. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
6. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance.
Ma G; Liu M; Du K; Zhong X; Gong S; Jiao L; Wei M
Biomed Res Int; 2019; 2019():8179145. PubMed ID: 30918899
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
Li H; Zou L; Shi J; Han X
Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
10. Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.
Leandro GS; Evangelista AF; Lobo RR; Xavier DJ; Moriguti JC; Sakamoto-Hojo ET
J Alzheimers Dis; 2018; 66(4):1483-1495. PubMed ID: 30400085
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of miRNA and mRNA expression in the blood of patients with Alzheimer's disease.
Wang Z; Shen L; Wang Y; Huang S
Mol Med Rep; 2020 Aug; 22(2):1053-1062. PubMed ID: 32468026
[TBL] [Abstract][Full Text] [Related]
12. Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer's Disease Based on Bioinformatics Analysis.
Wang X; Wang L
Med Sci Monit; 2020 Aug; 26():e924263. PubMed ID: 32812532
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Mitochondrial Dynamic-related Genes in the Peripheral Blood of Alzheimer's Disease Patients.
Pakpian N; Phopin K; Kitidee K; Govitrapong P; Wongchitrat P
Curr Alzheimer Res; 2020; 17(7):616-625. PubMed ID: 33023448
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm.
Ji W; An K; Wang C; Wang S
Hereditas; 2022 Oct; 159(1):38. PubMed ID: 36195955
[TBL] [Abstract][Full Text] [Related]
15. Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
Dobromyslin VI; Megherbi DB;
J Alzheimers Dis; 2022; 87(2):583-594. PubMed ID: 35311706
[TBL] [Abstract][Full Text] [Related]
16. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
[TBL] [Abstract][Full Text] [Related]
18. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
Bahado-Singh RO; Vishweswaraiah S; Aydas B; Yilmaz A; Metpally RP; Carey DJ; Crist RC; Berrettini WH; Wilson GD; Imam K; Maddens M; Bisgin H; Graham SF; Radhakrishna U
PLoS One; 2021; 16(3):e0248375. PubMed ID: 33788842
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
Lunnon K; Ibrahim Z; Proitsi P; Lourdusamy A; Newhouse S; Sattlecker M; Furney S; Saleem M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Coppola G; Geschwind D; Simmons A; Lovestone S; Dobson R; Hodges A;
J Alzheimers Dis; 2012; 30(3):685-710. PubMed ID: 22466004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
